Retroperitoneal spontaneous hemorrhage is defined as bleeding into the retroperitoneal space without trauma. Most common causes include anticoagulant therapy (warfarin, DOACs — 40-60% of all cases), renal tumor rupture (AML or RCC — known as Wunderlich syndrome), adrenal hemorrhage, abdominal aortic aneurysm (AAA) rupture, bleeding disorders, and vascular pathologies (pseudoaneurysm, arteriovenous malformation). Acute blood shows high density (50-80 HU) on non-contrast CT, resulting from iron atoms in hemoglobin increasing X-ray attenuation — a pathognomonic finding. Sentinel clot sign (densest clot area indicating bleeding source) provides critical clue for bleeding localization in emergency management. It is an emergency with potential hemodynamic instability and mortality can reach 20-30% in active bleeding.
Age Range
40-80
Peak Age
60
Gender
Male predominant
Prevalence
Uncommon
Spontaneous retroperitoneal hemorrhage develops through various pathophysiological mechanisms creating different clinical scenarios depending on etiology. In anticoagulant therapy (warfarin with INR >3 or under DOAC therapy), inhibition of the coagulation cascade leads to uncontrolled bleeding even from small vessel injuries that would normally be controlled by hemostasis; the psoas muscle and retroperitoneal fat tissue are common target locations because the retroperitoneal space contains large potential space and bleeding can spread without tamponade. In renal AML rupture (Wunderlich syndrome), abnormal dysplastic vessels in the tumor lack normal elastic lamina and smooth muscle layer → structurally weak vessel wall → aneurysm formation → spontaneous rupture; 4-5% of AMLs rupture with significantly increased risk in tumors >4 cm. The high CT density of acute blood (50-80 HU) results from iron atoms (Fe²⁺, atomic number Z=26) in hemoglobin increasing X-ray attenuation — density increases with hemoglobin concentration and clotted blood concentrates hemoglobin (60-80 HU). In subacute-chronic stages, blood products undergo chemical changes: oxy-Hb → deoxy-Hb (0-3 days) → intracellular met-Hb (3-7 days) → extracellular met-Hb (1-4 weeks) → hemosiderin/ferritin (>4 weeks), each stage showing different MR signal characteristics due to different paramagnetic properties. Sentinel clot sign's pathophysiological basis: fresh blood at the active bleeding point clots rapidly and this clot has the highest hemoglobin concentration → highest CT density localizes the bleeding source.
The highest density area (>60 HU, typically 65-80 HU) within the hematoma indicates the region closest to the bleeding source — clotting blood concentrates at the bleeding point because hemoglobin concentration is highest here and fibrin mesh compresses erythrocytes. This finding provides critical clue for localizing bleeding source and guides emergency intervention planning.
On non-contrast CT, high-density (50-80 HU) collection in the retroperitoneal space — acute blood. Sentinel clot sign: highest density area (65-80 HU) closest to bleeding source is critically important for bleeding localization. Blood may spread to psoas, perirenal, pararenal, or pelvic retroperitoneal spaces. Hematoma size is valuable for predicting hemodynamic impact; >500 mL hematoma carries risk of hemodynamic instability.
Report Sentence
A high-density (50-80 HU) collection is seen in the retroperitoneal space consistent with acute hematoma; bleeding source localized by sentinel clot sign.
On contrast-enhanced CT arterial phase, focal intense contrast accumulation (blush/jet) may be seen within hematoma — definitive evidence of active bleeding. This finding constitutes indication for urgent angiographic embolization or surgical intervention. Bleeding source (renal, lumbar, adrenal artery) is identified by extravasation location. Expansion of extravasation on delayed phase (pooling) indicates ongoing active bleeding.
Report Sentence
Active contrast extravasation (jet pattern) is seen within the hematoma consistent with active arterial bleeding; urgent intervention required.
In subacute hemorrhage phase (3 days-4 weeks), very high signal on T1 is seen — reflecting methemoglobin presence and is the most specific MRI finding for hemorrhage diagnosis. In acute phase (0-3 days), deoxy-Hb appears T1 iso/hypointense. In chronic phase (>4 weeks), hemosiderin shows low signal on both T1 and T2. MRI is superior to CT for staging blood products because different paramagnetic properties of blood products create different MR signal combinations.
Report Sentence
A collection showing hyperintense signal on T1 consistent with subacute hemorrhage (methemoglobin).
Variable T2 signal depending on hemorrhage stage: acute deoxy-Hb low T2 (intracellular paramagnetic effect), early subacute intra-methHb low T2, late subacute extra-methHb high T2, chronic hemosiderin very low T2 (blooming). Peripheral hemosiderin rim is characteristic of chronic hematoma and most prominently seen on T2*/GRE.
Report Sentence
The collection shows variable T2 signal characteristics with peripheral hemosiderin rim.
In large hematomas, hematocrit effect may be seen: cellular elements (erythrocytes) settle dependently due to gravity → high density (60-80 HU), serum floats → low density (20-30 HU), creating a distinct fluid-fluid level between these two phases. This finding suggests inactive bleeding and organizing hematoma; in active bleeding, homogeneous high density is expected.
Report Sentence
Fluid-fluid level (hematocrit effect) is seen within the hematoma consistent with organizing hematoma.
On SWI (Susceptibility Weighted Imaging) or GRE sequences, hemosiderin and deoxy-Hb show prominent blooming artifact — signal loss seen over a wider area than the actual lesion size. This finding is most prominent in chronic or subacute hematoma and confirms hemosiderin deposition. SWI is much more sensitive than conventional T2 for detecting blood products.
Report Sentence
Prominent blooming artifact is seen on SWI consistent with hemosiderin deposition.
Criteria
On anticoagulant therapy (warfarin INR >3, DOAC), spontaneous bleeding — most common etiology (40-60%)
Distinct Features
May be bilateral, widespread psoas and retroperitoneal fat involvement, urgent treatment with reversal agents (vitamin K, PCC, idarucizumab, andexanet alfa); usually low-flow bleeding from lumbar arteries; embolization rarely needed
Criteria
Renal AML or RCC rupture → perirenal hematoma
Distinct Features
Tumor may be visible within hematoma; fat density clue in AML, heterogeneously enhancing solid component in RCC; contrast CT provides tumor diagnosis; selective renal artery embolization + nephrectomy
Criteria
AAA rupture, lumbar artery pseudoaneurysm, renal artery aneurysm rupture
Distinct Features
Active contrast extravasation common, vascular pathology visible on contrast CT/CTA; draped aorta sign and crescent sign in AAA rupture; urgent surgical or endovascular repair
Distinguishing Feature
Abscess shows low density (10-30 HU) on non-contrast CT + rim enhancement + gas on contrast CT; hemorrhage shows high density (50-80 HU) + no rim enhancement + no gas. Clinically, abscess presents with fever/leukocytosis, hemorrhage with hemoglobin drop/hypotension.
Distinguishing Feature
Solid enhancing component dominant with irregular margins in sarcoma; hemorrhage is fluid density collection without solid component. Hemorrhagic areas may exist within sarcoma but dominant solid tumor is seen.
Distinguishing Feature
Lymphoma is solid homogeneous mass at soft tissue density (40-60 HU) on non-contrast CT; hemorrhage is fluid collection showing high density (50-80 HU) on non-contrast CT. Sentinel clot sign is pathognomonic for hemorrhage.
Urgency
emergentManagement
interventionalBiopsy
Not NeededFollow-up
specialist-referralRetroperitoneal hemorrhage is an emergency with rapidly developing hemodynamic instability. If hemodynamically unstable (SBP <90, HR >100, elevated lactate), aggressive fluid resuscitation and blood product transfusion is priority. If anticoagulant-related, urgent reversal: warfarin → IV vitamin K + 4-factor PCC; dabigatran → idarucizumab; apixaban/rivaroxaban → andexanet alfa or PCC. If active bleeding detected (contrast extravasation), angiographic selective embolization is first-line intervention with 85-95% success rate. Tumor rupture (Wunderlich syndrome) → embolization for bleeding control first, then nephrectomy planned. AAA rupture → urgent EVAR or open surgery. Stable hematoma (<500 mL, no active bleeding, hemodynamically stable) may be conservatively managed — serial CT size monitoring, anticoagulant dose adjustment. Underlying cause must be investigated in all cases.
Spontaneous retroperitoneal hemorrhage can be life-threatening. Hemodynamic instability may require emergent embolization or surgery. Anticoagulant dosing should be adjusted. After resolution, underlying mass should be investigated (with follow-up imaging).